| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.3 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |